BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16301119)

  • 1. Micro-array analysis of the effect of post-transurethral bladder tumor resection urine on transforming growth factor-beta1 dependent gene expression in transitional cell carcinoma.
    Zhang G; Cao Y; Xu Y; See WA
    Urol Oncol; 2005; 23(6):413-8. PubMed ID: 16301119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral bladder tumor resection alters fibronectin expression in transitional carcinoma cell lines.
    See WA; Xu Y; Gee K; Severson C; Cohen MB; Ladehoff D
    J Urol; 1997 Mar; 157(3):1136-43. PubMed ID: 9072558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of TGF-beta1 on differential gene expression profiles in human corneal epithelium studied by cDNA expression array.
    Hayashida-Hibino S; Watanabe H; Nishida K; Tsujikawa M; Tanaka T; Hori Y; Saishin Y; Tano Y
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1691-7. PubMed ID: 11431430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
    Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
    Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
    Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
    J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced TGF-beta1 expression and its target genes in human insulinomas.
    Nabokikh A; Ilhan A; Bilban M; Gartner W; Vila G; Niederle B; Nielsen JH; Wagner O; Base W; Luger A; Wagner L
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):674-82. PubMed ID: 18058603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
    Zhao X; Ramsey KE; Stephan DA; Russell P
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
    Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
    Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of newly established tumor lines from a spontaneous malignant schwannoma in F344 rats: nerve growth factor production, growth inhibition by transforming growth factor-beta1, and macrophage-like phenotype expression.
    Yamate J; Yasui H; Benn SJ; Tsukamoto Y; Kuwamura M; Kumagai D; Sakuma S; LaMarre J
    Acta Neuropathol; 2003 Sep; 106(3):221-33. PubMed ID: 12811582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.
    Elsamman E; Fukumori T; Ewis AA; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Takahashi M; Nishitani MA; Baba Y; Kanayama HO
    Urol Oncol; 2006; 24(2):109-15. PubMed ID: 16520272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
    Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
    Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
    Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W
    J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J; Hurta RA
    Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1-induced hypertrophy and matrix expression in human bladder smooth muscle cells.
    Howard PS; Kucich U; Coplen DE; He Y
    Urology; 2005 Dec; 66(6):1349-53. PubMed ID: 16360482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oxidized regenerated cellulose on the expression of extracellular matrix and transforming growth factor-beta1 in human peritoneal fibroblasts and mesothelial cells.
    Gago LA; Saed GM; Wang RX; Kruger M; Diamond MP
    Am J Obstet Gynecol; 2003 Dec; 189(6):1620-5; discussion 1625-6. PubMed ID: 14710085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
    Ito M; Nishiyama H; Kawanishi H; Matsui S; Guilford P; Reeve A; Ogawa O
    J Urol; 2007 Sep; 178(3 Pt 1):1073-9. PubMed ID: 17644138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.